Want to join the conversation?
$BIIB's 4Q15 product sales grew 6% YoverY to $2.43Bil, up from $2.28Bil a year earlier. Tecfidera's revenue for the quarter was $993MM, as the sales in the US increased slightly to $785MM. Revenue for Tysabri fell to $480.7MM, while Avonex fell 13% YoverY to $637.2MM. Meanwhile, quarterly sales of Plegridy doubled to $102MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?